top of page
Search Results

461 items found for "G-protein coupled receptor signaling"

  • GPR125 (ADGRA3) is an autocleavable adhesion GPCR that traffics with Dlg1 to the basolateral...

    protein-coupled receptors (GPCRs) is defined by an N-terminal large extracellular region that contains These receptors are expressed widely and involved in various functions including development, angiogenesis appears to occur at an atypical GPCR proteolysis site within the GAIN domain during an early stage of receptor requires the C-terminal PDZ-domain-binding motif of GPR125 and its interaction with the cell polarity protein Thus, the basolateral protein GPR125, an autocleavable adhesion GPCR, appears to play a crucial role

  • Statin-induced increase in actin polymerization modulates GPCR dynamics and compartmentalization

    Specifically, we explore the role of actin cytoskeleton in regulating the dynamics of the serotonin1A receptor , a crucial neurotransmitter G protein-coupled receptor (GPCR) that plays a major role in the generation For this, we analyzed the lateral dynamics of the serotonin1A receptor in cholesterol-depleted cells Our results indicate that lateral diffusion parameters of serotonin1A receptors in normal cells are consistent Interestingly, these parameters are altered in cholesterol-depleted cells and the receptor exhibits dynamic

  • Ono Enters into Collaboration Agreement with Domain Therapeutics and Université de Montréal for ...

    ”) and Université de Montréal (Québec, Canada; “UdM”), to discover novel small molecules targeting G-Protein Coupled Receptors (GPCRs) in a metabolic disease area."

  • Confo Therapeutics receives €1.7 million VLAIO grant for further research on GPCR modulators for ...

    The grant should help expand Confo Therapeutic ’s research on G protein-coupled receptor (GPCR) drug

  • Immunomodulatory Role of Neuropeptides in the Cornea

    Much remains to be known regarding the details of neuropeptide signaling and how it contributes to pathophysiology , which is likely due to complex interactions among neuropeptides, receptor isoform-specific signaling

  • Tectonic Therapeutic Strengthens Leadership Team

    pre-clinical stage biotechnology company transforming the discovery of novel GPCR-targeted therapies (G-Protein Coupled Receptors), today announced the promotion of Senior Vice President, Head of Research, Peter

  • Finding needles in haystacks: Omass unveils pipeline aimed at tough-to-drug targets

    orally available small molecules aimed at intractable and poorly drugged membrane and complex-bound protein The targets, including G protein-coupled receptors (GPCRs), intracellular protein complexes and solute

  • Label-free LC-MS based assay to characterize small molecule compound binding to cells

    This assay was applied to various target classes, with particular emphasis on those for which protein-based In one example, to study a G protein coupled receptor (GPCR), we used one antagonist as probe and multiple

  • Latrophilin-1 drives neuron morphogenesis and shapes chemo- and mechanosensation-dependent ...

    Recently, it has been shown that murine Latrophilins mediate classical G-protein signals to drive synaptogenesis This trans function is physiologically relevant in copulation behavior. specific LAT-1-positive neurons and first insights into the genetic network that is modulated by the receptor Latrophilins are essential for neuronal physiology, possibly complementing canonical functions via G protein-mediated signaling.

  • Primary cilia and SHH signaling impairments in human and mouse models of Parkinson’s disease

    Furthermore, in sPD models, the shortening of PC is accompanied by increased Sonic Hedgehog (SHH) signal Inhibiting overactive SHH signaling may be a potential neuroprotective therapy for sPD."

  • Verily links up with Sosei Heptares for GPCR drug discovery

    January 2022 "G-protein-coupled receptors’ star has been on the rise in biotech in recent years as researchers

  • Septerna emerges with $100M to spark 'second golden age' of prolific drug target GPCR with ...

    with pioneer as co-founder "J an 27, 2022 07:00am Septerna wants to spark a second golden age in G-protein-coupled receptor drug discovery.

  • Lipid Modulation of a Class B GPCR: Elucidating the Modulatory Role of PI(4,5)P 2 Lipids

    4,5-bisphosphate (PI(4,5)P2) lipids have been shown to stabilize an active conformation of class A G-protein coupled receptors (GPCRs) through a conserved binding site, not present in class B GPCRs. previous molecular dynamics (MD) simulation studies have shown PI(4,5)P2 interacting with the Glucagon receptor

  • GPCR voltage dependence controls neuronal plasticity and behavior

    G-protein coupled receptors (GPCRs) play a paramount role in diverse brain functions. This voltage dependent potentiation is abolished in mutant animals expressing a voltage independent receptor Depolarization alone, without a muscarinic agonist, results in a nicotinic ionotropic receptor potentiation that is mediated by muscarinic receptor voltage dependency. Finally, muscarinic receptor voltage independence causes a strong behavioral effect of increased odor

  • Emerging approaches for decoding neuropeptide transmission

    includes their post-translational processing, release from dense core vesicles, and ability to activate G-protein-coupled receptors (GPCRs).

  • HDX-MS-optimized approach to characterize nanobodies as tools for biochemical and structural ...

    phosphoinositide 3-kinases There is considerable interest in developing antibodies as modulators of signaling One of the most important signaling pathways in higher eukaryotes is the phosphoinositide 3-kinase (PI3K PI3Kγ is a critical component in multiple immune signaling processes and is dependent on activation by Ras and G protein-coupled receptors (GPCRs) to mediate its cellular roles.

  • 📰 GPCR Weekly News, December 11 to 17, 2023

    GPCR Activation and Signaling GPCR screening reveals that the metabolite receptor HCAR3 regulates epithelial 1-arrestin complex unravels the biased signaling mechanism GPCR Binders, Drugs, and more Semi-synthetic nanobody-ligand conjugates exhibit tunable signaling properties and enhanced transcriptional outputs and Exhibition June 2 - 7, 2024 | Chemotactic Cytokines June 9 - 14, 2024 | 2024 Phosphorylation and G-Protein Mediated Signaling Networks June 25 - 29, 2024 | FENS Forum 2024 October 2 - 4, 2024 | 9th GPCRs in

  • Rhodopsin as a Molecular Target to Mitigate Retinitis Pigmentosa

    These disorders are mainly related to the abnormalities in the rod G protein-coupled receptor (GPCR), Targeting rhodopsin with small molecule chaperones to improve the folding and stability of the mutant receptor

  • Combined docking and machine learning identify key molecular determinants of ligand pharmacological

    September 2022 "G proteincoupled receptors (GPCRs) are valuable therapeutic targets for many diseases We hypothesized that there is a common set of receptor interactions made by ligands of diverse structures β2AR structures, generating ca 75 000 docking poses and predicted all atomic interactions between the receptor

  • Domain Therapeutics Raises $42m Series A Financing

    biopharmaceutical company specializing in the research and development of innovative drugs targeting G Protein-Coupled Receptors (GPCRs) in immuno-oncology, announced today the closing of a US $42m (€39m)

  • GPCR Therapeutics Expands Scientific Advisory Board

    international biopharmaceutical company with an innovative approach to drug discovery based on targeting G Protein Coupled Receptors (GPCR) pairs, today announced four appointments to its Scientific Advisory

  • Research Network on Signal Transduction (ERNEST) has established an Emergency Fund for Ukrainian ...

    March 2022 ERNEST has established an Emergency Fund for Ukrainian researchers. "General Eligibility Researchers affiliated to any legal entity in Ukraine (for example, schools and universities, research centers, governmental institutions, or private companies) Deadlines Start of the project: now End of the project: 31 October 2022 SHORT-TERM SCIENTIFIC MISSIONS (STSM) We offer short-term scientific mission grants to Ukrainian researchers who have been recently displaced by the war, or those who can travel to institutions participating in ERNEST COST Action. The purpose of the STSM is to carry out a collaborative research project on topics relevant to the network. Our scientific perspective is broad, and we are happy to consider any research proposals from those in need." Read more at the source #DrGPCR #GPCR #IndustryNews

  • The Adhesion GPCR VLGR1/ADGRV1 Regulates the Ca2+ Homeostasis at Mitochondria-Associated ER Membrane

    October 2022 "The very large G protein-coupled receptor (VLGR1, ADGRV1) is the largest member of the Affinity proteomics revealed that in the interactome of VLGR1, molecules are enriched that are associated We confirmed the interaction of VLGR1 with key proteins of MAMs by pull-down assays in vitro complemented

  • Drug Discovery Picks Up the Pace, Stays on Target

    They include small molecules that conditionally modulate proteins in their functional state; three-dimensional high-throughput drug screening, drug efficacy analyses, and toxicity studies; technologies that stabilize G proteincoupled receptors (GPCRs) to enable the discovery of agonistic biologics; and automated instrumentation

  • Confo Therapeutics Doses First Subjects In Phase 1 Clinical Trial Of CFTX-1554 For The Treatment ...

    Ghent, Belgium – March 10, 2022 – Confo Therapeutics , a leader in the discovery of medicines targeting G-protein coupled receptors (GPCRs), today announced that the first subjects have been dosed in the company’s first-in-human trial of their clinical candidate CFTX-1554, a novel inhibitor of the angiotensin II type 2 receptor

  • In vivo detection of GPCR-dependent signaling using fiber photometry and FRET-based biosensors

    August 2022 "Genetically encoded fluorescent biosensors allow intracellular signaling dynamics to be FRET), and we have recently developed a simple approach for in vivo detection of FRET-based biosensor signals By combining fiber photometry with FRET-based biosensors, we were able to track GPCR-dependent signaling Recording from specific neuronal populations, we can quantify intracellular signaling while simultaneously

  • Newly launched antibody libraries put hard-to-drug targets within reach

    The drugs also target relatively low-hanging fruit: like cytokines or tyrosine kinase receptors. To target hard-to-drug targets like G protein-coupled receptors (GPCRs), more libraries, including better

  • 📰 GPCR Weekly News, November 13 to 19, 2023

    Butyrate induces STAT3/HIF-1α/IL-22 signaling via GPCR and HDAC3 inhibition to activate autophagy in Endosomal signaling via cAMP in parathyroid hormone (PTH) type 1 receptor biology β-arrestin1 is an E3 Nematode Species: Bursaphelenchus xylophilus and B. mucronatus GPCRs in Oncology and Immunology GPCR signaling Industry News OMass Therapeutics Welcomes Melissa Faris as Chief Business Officer Septerna: Revitalizing G-Protein Coupled Receptor Drug Discovery Orion’s VP Drug Discovery, Dr.

bottom of page